r has recently experienced a sharp correction after hitting a peak near ₹740 in late 2025. It reached a low around ₹540-₹560 in early February 2026. However the last few candles show a strong V-shaped recovery with the price jumping back up to the ₹603 level.
The ₹615 - ₹620 zone is a crucial hurdle. This area acted as support previously and might now act as resistance. Breaking above this could lead the stock toward ₹660. The ₹540 - ₹550 zone is now the floor. As long as the stock stays above this the medium-term outlook remains positive. The ultimate target for bulls remains the previous peak of ₹740.
The stock is in a recovery phase. While the long-term trend is bullish short-term traders should watch if it can sustain above ₹620. If it fails to cross that level it might consolidate between ₹560 and ₹610 for some time before making the next big move. The recovery candles show decent buying interest.
The Future of Healthcare Demand in India
The demand for healthcare in India is seeing an unprecedented surge due to a growing middle class and increased health awareness. With a rising elderly population and a higher prevalence of lifestyle diseases, the need for quality hospital beds and specialized treatments is at an all-time high. Additionally, government schemes like Ayushman Bharat and the expansion of private health insurance are making private healthcare more accessible to millions. Companies like Aster DM are well-positioned to benefit from this long-term structural shift in the Indian economy.